[English] 日本語
Yorodumi
- PDB-1d00: STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 1d00
TitleSTRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5-RESIDUE CD40 PEPTIDE
Components
  • B-CELL SURFACE ANTIGEN CD40
  • TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
KeywordsAPOPTOSIS / B-SANDWICH / PROTEIN-PEPTIDE COMPLEX
Function / homology
Function and homology information


cellular response to erythropoietin / CD40 receptor binding / tumor necrosis factor receptor superfamily complex / B cell mediated immunity / sphingolipid binding / immune response-regulating cell surface receptor signaling pathway / response to peptide / positive regulation of protein kinase C signaling / IRE1-TRAF2-ASK1 complex / Defective RIPK1-mediated regulated necrosis ...cellular response to erythropoietin / CD40 receptor binding / tumor necrosis factor receptor superfamily complex / B cell mediated immunity / sphingolipid binding / immune response-regulating cell surface receptor signaling pathway / response to peptide / positive regulation of protein kinase C signaling / IRE1-TRAF2-ASK1 complex / Defective RIPK1-mediated regulated necrosis / varicosity / TRAF2-GSTP1 complex / CD40 signaling pathway / negative regulation of glial cell apoptotic process / Regulation by c-FLIP / CASP8 activity is inhibited / Dimerization of procaspase-8 / tumor necrosis factor binding / TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway / interleukin-17-mediated signaling pathway / programmed necrotic cell death / TNF signaling / Caspase activation via Death Receptors in the presence of ligand / positive regulation of isotype switching to IgG isotypes / CD40 receptor complex / signal transduction involved in regulation of gene expression / positive regulation of endothelial cell apoptotic process / mitogen-activated protein kinase kinase kinase binding / positive regulation of tumor necrosis factor-mediated signaling pathway / thioesterase binding / tumor necrosis factor receptor binding / mRNA stabilization / positive regulation of extrinsic apoptotic signaling pathway / regulation of immunoglobulin production / vesicle membrane / TNFR1-induced proapoptotic signaling / non-canonical NF-kappaB signal transduction / RIPK1-mediated regulated necrosis / TRAF6 mediated IRF7 activation / B cell activation / response to cobalamin / B cell proliferation / defense response to protozoan / response to type II interferon / TRAF6 mediated NF-kB activation / protein K63-linked ubiquitination / regulation of JNK cascade / cellular response to interleukin-1 / intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress / cellular response to nitric oxide / regulation of protein-containing complex assembly / positive regulation of blood vessel endothelial cell migration / protein autoubiquitination / signaling adaptor activity / ubiquitin ligase complex / positive regulation of B cell proliferation / positive regulation of tyrosine phosphorylation of STAT protein / positive regulation of JUN kinase activity / tumor necrosis factor-mediated signaling pathway / positive regulation of interleukin-12 production / positive regulation of interleukin-2 production / phosphatidylinositol 3-kinase/protein kinase B signal transduction / response to endoplasmic reticulum stress / positive regulation of GTPase activity / TNFR1-induced NF-kappa-B signaling pathway / Regulation of NF-kappa B signaling / antigen binding / TNFR2 non-canonical NF-kB pathway / Regulation of TNFR1 signaling / positive regulation of MAP kinase activity / RING-type E3 ubiquitin transferase / protein catabolic process / Regulation of necroptotic cell death / cytoplasmic side of plasma membrane / positive regulation of T cell cytokine production / platelet activation / positive regulation of DNA-binding transcription factor activity / intracellular calcium ion homeostasis / cellular response to mechanical stimulus / positive regulation of angiogenesis / ubiquitin-protein transferase activity / Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell / cellular response to tumor necrosis factor / signaling receptor activity / positive regulation of NF-kappaB transcription factor activity / protein-macromolecule adaptor activity / cell cortex / protein-containing complex assembly / cellular response to lipopolysaccharide / protein phosphatase binding / regulation of apoptotic process / positive regulation of canonical NF-kappaB signal transduction / defense response to virus / molecular adaptor activity / Ub-specific processing proteases / inflammatory response / positive regulation of protein phosphorylation / membrane raft / protein domain specific binding / external side of plasma membrane
Similarity search - Function
Tumour necrosis factor receptor 5 / Tumour necrosis factor receptor 5, N-terminal / : / TNF receptor-associated factor 2 / TNF receptor-associated factor 2, MATH domain / : / TRAF2, second zinc finger / TNF receptor-associated factor, BIRC3 binding domain / TNF receptor-associated factor BIRC3 binding domain / TRAF-type zinc finger ...Tumour necrosis factor receptor 5 / Tumour necrosis factor receptor 5, N-terminal / : / TNF receptor-associated factor 2 / TNF receptor-associated factor 2, MATH domain / : / TRAF2, second zinc finger / TNF receptor-associated factor, BIRC3 binding domain / TNF receptor-associated factor BIRC3 binding domain / TRAF-type zinc finger / TNF receptor-associated factor TRAF, metazoa / Zinc finger, TRAF-type / Zinc finger TRAF-type profile. / : / TRAF/meprin, MATH domain / Apoptosis, Tumor Necrosis Factor Receptor Associated Protein 2; Chain A / Apoptosis, Tumor Necrosis Factor Receptor Associated Protein 2; Chain A / TNFR/NGFR family cysteine-rich region domain profile. / TNFR/NGFR cysteine-rich region / TNFR/NGFR family cysteine-rich region signature. / Tumor necrosis factor receptor / nerve growth factor receptor repeats. / TNFR/NGFR cysteine-rich region / MATH/TRAF domain / MATH/TRAF domain profile. / meprin and TRAF homology / TRAF-like / Zinc finger, C3HC4 RING-type / Zinc finger, C3HC4 type (RING finger) / Zinc finger, RING-type, conserved site / Zinc finger RING-type signature. / Ring finger / Zinc finger RING-type profile. / Zinc finger, RING-type / Zinc finger, RING/FYVE/PHD-type / Sandwich / Mainly Beta
Similarity search - Domain/homology
: / Tumor necrosis factor receptor superfamily member 5 / TNF receptor-associated factor 2
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / Resolution: 2 Å
AuthorsYe, H. / Park, Y.C. / Kreishman, M. / Kieff, E. / Wu, H.
Citation
Journal: Mol.Cell / Year: 1999
Title: The structural basis for the recognition of diverse receptor sequences by TRAF2.
Authors: Ye, H. / Park, Y.C. / Kreishman, M. / Kieff, E. / Wu, H.
#1: Journal: Nature / Year: 1999
Title: Structural Basis for Self-Association and Receptor Recognition of Human Traf2
Authors: Park, Y.C. / Burkitt, V. / Villa, A.R. / Tong, L. / Wu, H.
History
DepositionSep 7, 1999Deposition site: RCSB / Processing site: RCSB
Revision 1.0Mar 29, 2000Provider: repository / Type: Initial release
Revision 1.1Apr 27, 2008Group: Version format compliance
Revision 1.2Jul 13, 2011Group: Version format compliance
Revision 1.3Oct 4, 2017Group: Refinement description / Category: software
Revision 1.4Jan 31, 2018Group: Experimental preparation / Category: exptl_crystal_grow / Item: _exptl_crystal_grow.temp

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
B: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
C: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
D: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
E: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
F: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
G: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
H: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
I: B-CELL SURFACE ANTIGEN CD40
J: B-CELL SURFACE ANTIGEN CD40
K: B-CELL SURFACE ANTIGEN CD40
L: B-CELL SURFACE ANTIGEN CD40
M: B-CELL SURFACE ANTIGEN CD40
N: B-CELL SURFACE ANTIGEN CD40
O: B-CELL SURFACE ANTIGEN CD40
P: B-CELL SURFACE ANTIGEN CD40


Theoretical massNumber of molelcules
Total (without water)156,82916
Polymers156,82916
Non-polymers00
Water1,26170
1
A: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
I: B-CELL SURFACE ANTIGEN CD40

A: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
I: B-CELL SURFACE ANTIGEN CD40

A: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
I: B-CELL SURFACE ANTIGEN CD40


Theoretical massNumber of molelcules
Total (without water)58,8116
Polymers58,8116
Non-polymers00
Water543
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
crystal symmetry operation2_555z,x,y1
crystal symmetry operation3_555y,z,x1
2
C: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
D: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
E: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
K: B-CELL SURFACE ANTIGEN CD40
L: B-CELL SURFACE ANTIGEN CD40
M: B-CELL SURFACE ANTIGEN CD40


Theoretical massNumber of molelcules
Total (without water)58,8116
Polymers58,8116
Non-polymers00
Water905
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area6810 Å2
ΔGint-34 kcal/mol
Surface area22840 Å2
MethodPISA
3
F: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
G: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
H: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
N: B-CELL SURFACE ANTIGEN CD40
O: B-CELL SURFACE ANTIGEN CD40
P: B-CELL SURFACE ANTIGEN CD40


Theoretical massNumber of molelcules
Total (without water)58,8116
Polymers58,8116
Non-polymers00
Water543
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area6670 Å2
ΔGint-35 kcal/mol
Surface area23210 Å2
MethodPISA
4
B: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
J: B-CELL SURFACE ANTIGEN CD40

B: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
J: B-CELL SURFACE ANTIGEN CD40

B: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2
J: B-CELL SURFACE ANTIGEN CD40


Theoretical massNumber of molelcules
Total (without water)58,8116
Polymers58,8116
Non-polymers00
Water543
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
crystal symmetry operation2_654z+1,x,y-11
crystal symmetry operation3_564y,z+1,x-11
Unit cell
Length a, b, c (Å)111.4, 111.4, 111.4
Angle α, β, γ (deg.)103.7, 103.7, 103.7
Int Tables number146
Space group name H-MR3

-
Components

#1: Protein
TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2


Mass: 19006.916 Da / Num. of mol.: 8 / Fragment: TRAF DOMAIN
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Plasmid: PET24D / Production host: Escherichia coli (E. coli) / References: GenBank: 1363002, UniProt: Q12933*PLUS
#2: Protein/peptide
B-CELL SURFACE ANTIGEN CD40


Mass: 596.653 Da / Num. of mol.: 8 / Fragment: ACETYLATED 5-RESIDUE PEPTIDE / Source method: obtained synthetically
Details: THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE OF THIS PEPTIDE NATURALLY OCCURS IN HUMANS (HOMO SAPIENS)
References: UniProt: P25942
#3: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 70 / Source method: isolated from a natural source / Formula: H2O

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION

-
Sample preparation

CrystalDensity Matthews: 2.64 Å3/Da / Density % sol: 53.33 %
Crystal growTemperature: 293 K / Method: vapor diffusion / pH: 6
Details: PEG4K, MES, Ph6.0, VAPOR DIFFUSION, temperature 20K
Crystal grow
*PLUS
pH: 6 / Method: unknown
Components of the solutions
*PLUS
IDConc.Common nameCrystal-IDSol-ID
18-15 %PEG40001reservoir
20.1 MMES1reservoir

-
Data collection

DiffractionMean temperature: 110 K
Diffraction sourceSource: SYNCHROTRON / Site: CHESS / Beamline: A1 / Wavelength: 0.937
DetectorType: ADSC / Detector: CCD / Date: Dec 1, 1998
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 0.937 Å / Relative weight: 1
ReflectionResolution: 2→20 Å / % possible obs: 100 % / Rmerge(I) obs: 0.055
Reflection shellHighest resolution: 2 Å / Rmerge(I) obs: 0.18 / % possible all: 99
Reflection
*PLUS
% possible obs: 100 %
Reflection shell
*PLUS
% possible obs: 99.9 % / Rmerge(I) obs: 0.18

-
Processing

Software
NameClassification
DENZOdata reduction
SCALEPACKdata scaling
CNSrefinement
RefinementResolution: 2→20 Å / Rfactor Rfree: 0.254 / Rfactor Rwork: 0.219 / σ(F): 2 / σ(I): 0
Refinement stepCycle: LAST / Resolution: 2→20 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms10600 0 0 70 10670

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbjlc1.pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more